LIP
MEDP icon

Liontrust Investment Partners’s Medpace MEDP Stock Holding History

Liontrust Investment Partners’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$455K Sell
859
-218
-20% -$101K 0.01% 167
2026
Q1 		$517K Sell
1,077
-46
-4% -$23.6K 0.01% 170
2025
Q4 		$631K Sell
1,123
-628
-36% -$356K 0.01% 179
2025
Q3 		$900K Sell
1,751
-46
-3% -$20.1K 0.01% 160
2025
Q2 		$564K Sell
1,797
-31
-2% -$9.31K 0.01% 181
2025
Q1 		$557K Buy
+1,828
New +$615K 0.01% 187

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Liontrust Investment Partners's MEDP Position: Q2 2026 in Review

Liontrust Investment Partners reduced its Medpace (MEDP) stake by 20% in Q2 2026, selling an estimated $101K and leaving 859 shares worth $455K. The position accounts for 0.01% of the portfolio, ranked #167.

Liontrust Investment Partners first reported a position in MEDP in Q1 2025 and has held it in 6 quarters since. The position peaked at $900K in Q3 2025. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Liontrust Investment Partners held 859 shares of Medpace worth $455K as of Q2 2026.
  • Liontrust Investment Partners sold 218 Medpace shares in Q2 2026, an estimated $101K.
  • Medpace made up 0.01% of Liontrust Investment Partners's portfolio in Q2 2026, its #167 holding.
  • Liontrust Investment Partners first reported a position in Medpace in Q1 2025 and has held it in 6 quarters since.
  • Liontrust Investment Partners's Medpace position peaked at $900K in Q3 2025.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Liontrust Investment Partners's 13F filing for Q2 2026, filed 18 Aug 2026.